Sorry, you need to enable JavaScript to visit this website.

CAMPTOSAR® (irinotecan HCl) Boxed Warning

WARNING: DIARRHEA and MYELOSUPPRESSION

  • Early and late forms of diarrhea can occur. Early diarrhea may be accompanied by cholinergic symptoms which may be prevented or ameliorated by atropine. Late diarrhea can be life threatening and should be treated promptly with loperamide. Monitor patients with diarrhea and give fluid and electrolytes as needed. Institute antibiotic therapy if patients develop ileus, fever, or severe neutropenia. Interrupt CAMPTOSAR and reduce subsequent doses if severe diarrhea occurs [see Dosage and Administration (2.2) and Warnings and Precautions (5.1)].
  • Severe myelosuppression may occur [see Warnings and Precautions (5.2)].

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for CAMPTOSAR®